Acrobiosystems Co.,Ltd. (SHE:301080)
China · Delayed Price · Currency is CNY 62.62
-0.03 (-0.05%)
At close: Jan 22, 2026
Acrobiosystems Market Cap
Acrobiosystems has a market cap or net worth of 10.44 billion as of January 22, 2026. Its market cap has increased by 98.23% in one year.
Market Cap
10.44B
Enterprise Value
8.63B
Revenue
794.52M
Ranking
n/a
PE Ratio
60.85
Stock Price
62.62
Market Cap Chart
Since October 18, 2021, Acrobiosystems's market cap has decreased from 13.51B to 10.44B, a decrease of -22.70%. That is a compound annual growth rate of -5.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 10.45B | 16.02% |
| Dec 31, 2025 | 9.00B | 70.36% |
| Dec 31, 2024 | 5.28B | -25.26% |
| Dec 29, 2023 | 7.07B | -13.93% |
| Dec 30, 2022 | 8.22B | -51.36% |
| Dec 31, 2021 | 16.89B | 25.06% |
| Oct 18, 2021 | 13.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 406.83B |
| WuXi AppTec | 305.26B |
| Shenzhen Mindray Bio-Medical Electronics | 242.11B |
| Sichuan Biokin Pharmaceutical | 126.75B |
| Shanghai United Imaging Healthcare | 110.18B |
| Aier Eye Hospital Group | 105.32B |
| Zhangzhou Pientzehuang Pharmaceutical., | 101.25B |
| Yunnan Baiyao Group Co.,Ltd | 100.31B |